Larimar Therapeutics, Inc. - Common Stock (NQ:LRMR)

2.860 -0.100 (-3.38%)

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Larimar Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Nasdaq Rises 75 Points; Tower Semiconductor Posts Upbeat Q1 Results ↗

May 15, 2023

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 75 points on Monday. The Dow traded up 0.07% to 33,325.35 while the NASDAQ rose 0.62% to 12,360.60. The S&P...

Via Benzinga

Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

May 15, 2023

Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.

Via Benzinga

After One Year Of Regulatory Hold, Larimar's Ataxia Candidate Sees Some Hope ↗

September 14, 2022

Via Benzinga

Larimar Proposes Another Mid-Stage Study For Rare Neuromuscular Disorder ↗

August 12, 2022

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

May 15, 2023

Via Benzinga

Crude Oil Rises 1.5%; Athenex Shares Plummet ↗

May 15, 2023

U.S. stocks traded mixed midway through trading, with the Dow Jones trading slightly lower on Monday. The Dow traded down 0.03% to 33,290.69 while the NASDAQ rose 0.35% to 12,328.38. The S&P 500, also...

Via Benzinga

Larimar Therapeutics Discloses Lower Dose Data Of Investigational Drug For Rare Neurodegenerative Disorder, Shares Plummet ↗

May 15, 2023

Larimar Therapeutics Inc (NASDAQ: LRMR) announced preliminary topline data from the 25 mg cohort of its Phase 2 trial of CTI-1601 in participants with

Via Benzinga

US Stocks Mixed; NY Manufacturing Activity Shrinks In May ↗

May 15, 2023

U.S. stocks traded mixed this morning, with the Dow Jones dropping around 75 points on Monday. Following the market opening Monday, the Dow traded down 0.23% to 33,224.02 while the NASDAQ rose 0.18% to...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

May 15, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

March 01, 2023

It's time to start the day with another breakdown of the biggest pre-market stock movers traders need to know about on Wednesday!

Via InvestorPlace

Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market ↗

October 05, 2022

Following insider buying is a savvy way for retail investors to profit even when a bear market is raging on Wall Street. Here are 15 stocks.

Via InvestorPlace

$35 Million Bet On This Penny Stock? Check Out These 3 Stocks Under $4 Insiders Are Buying ↗

September 21, 2022

The Dow Jones dropped by more than 300 points on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2022 ↗

October 19, 2022

Upgrades

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 19, 2022 ↗

September 19, 2022

Upgrades

Via Benzinga

Important Biotech Catalysts For September 14, 2022 - End Of The Day Summary ↗

September 14, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 18, 2022

Via Benzinga

This Biotechnology Stock Tumbled 37%; Here Are 70 Biggest Movers From Yesterday ↗

August 19, 2022

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 135.9% to close at $2.17 on Thursday.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

August 12, 2022

Via Benzinga

Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday ↗

August 15, 2022

Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results.

Via Benzinga

Why Twin Vee Powercats Is Trading Higher By Around 90%, Here Are 84 Stocks Moving In Friday's Mid-Day Session ↗

August 12, 2022

Gainers Twin Vee Powercats Co. (NASDAQ: VEEE) shares jumped 90% to $7.60 after the company said Q2 sales results were up year over year.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

August 12, 2022

Good morning! We're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday!

Via InvestorPlace

Market Cues For Today: S&P, Nasdaq Futures Push Higher As Investors Await Consumer Sentiment Data ↗

August 12, 2022

U.S. index futures are pointing to a moderately positive open on Wall Street on Friday following the lackluster close in the previous session.

Via Benzinga

Why Is Toast Trading Higher By 20%: Here Are 34 Stocks Moving Premarket ↗

August 12, 2022

Gainers Neptune Wellness Solutions Inc. (NASDAQ: NEPT) shares rose 66.9% to $2.37 in pre-market trading. Neptune Wellness Solutions recently announced voluntary delisting from Toronto Stock Exchange.

Via Benzinga

Recap Of Thursday's Biotech Catalysts - End Of the Day Summary ↗

August 11, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 11, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

July 21, 2022

During Thursday's trading, 50 companies set new 52-week lows.

Via Benzinga

Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday ↗

August 09, 2022

Gainers Helbiz, Inc. (NASDAQ: HLBZ) jumped 114.6% to close at $1.61 on Monday after climbing over 27% on Friday.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

August 02, 2022

Tuesday's session saw 63 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

July 28, 2022

On Thursday, 108 companies set new 52-week lows.

Via Benzinga

Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday ↗

July 05, 2022

Gainers Omeros Corporation (NASDAQ: OMER) jumped 68.7% to close at $4.64. Clovis Oncology, Inc. (NASDAQ: CLVS) gained 58.3% to settle at $2.85 on Friday.

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.